Gabriela Tomescu

Corporate Officer/Principal at Apneon, Inc.

Consumer Services

Health Technology

Profile

Gabriela Tomescu is currently working as the Director of Intellectual Property at Apneon, Inc. She has an undergraduate and graduate degree from The Trustees of Columbia University in The City of New York, an undergraduate degree from The Ohio State University, and a graduate degree from Georgetown University.

Gabriela Tomescu active positions

Companies	Position	Start
Apneon, Inc. Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA.	Corporate Officer/Principal	2005-08-31

All active positions of Gabriela Tomescu

Training of Gabriela Tomescu

The Ohio State University	Undergraduate Degree
The Trustees of Columbia University in The City of New York	Graduate Degree
Georgetown University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gabriela Tomescu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Apneon, Inc. Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA.	Health Technology